Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | PAM | P19021 | 1/20 | 0.59 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.57 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 1/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27498764 | 0.96 | TSHR (0.59) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL28249350 | 0.93 | TSHR (0.56) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL28250151 | 0.93 | TSHR (0.56) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL13397998 | 0.88 | TSHR (0.67) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL6898542 | 0.87 | TSHR (0.56) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| Acetic Acid Isobutyl Ester SCHEMBL5070861 | 0.86 | TSHR (0.51) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL27292042 | 0.86 | TSHR (0.59) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL10835812 | 0.86 | TSHR (0.59) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL10836435 | 0.86 | TSHR (0.59) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| SCHEMBL30136433 | 0.85 | TSHR (0.48) | TSHRALDH1A1MAPK1L3MBTL1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | claimed |
| CN-114403143-B | Anti-freezing quaternary ammonium salt composition and preparation method and application thereof | 广州蓝月亮实业有限公司 | 2024-07-12 | — | — | CN | claimed |
| EP-4391827-A1 | METHOD OF MITIGATING OFF-ODORS | Givaudan SA (CH) | 2024-07-03 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-117897055-A | Method for reducing abnormal odor | 奇华顿股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| CN-1625411-A | Combination of a NSAID and a PDE-4 inhibitor | ALTANA PHARMA AG (DE) | 2005-06-08 | — | — | CN | claimed |
| CN-1572335-A | Self-Service respiratory vaccination instrument for SARS infectious disease | CONG FANZI (CN) | 2005-02-02 | — | — | CN | claimed |
| CN-1520846-A | Quick-effective aerosol with plant aroma and its preparation | 丛繁滋 | 2004-08-18 | — | — | CN | claimed |
| CN-1500477-A | Quick result aerosol with plant aroma and its preparation | 丛繁滋 | 2004-06-02 | — | — | CN | claimed |
| CN-1475204-A | Medicinal Composition, dry powder vapor, nebula, nebula auxiliary preparation for use through mouth and nose and its preparation method | 丛繁滋 | 2004-02-18 | — | — | CN | claimed |
| WO-1998029069-A2 | METHOD FOR CHANGING THE REFRACTIVE POWER OF AN EYE | ALLERGAN SALES, INC. (US) | 1998-07-09 | — | — | WO | claimed |
| US-5360611-A | Antiinflammatory | ALCON LABORATORIES, INC. (US) | 1994-11-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | TSHR 4528/4885ALDH1A1 44/4885MAPK1 4256/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | TSHR 4168/4885ALDH1A1 57/4885MAPK1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.